{"name":"TCM Biotech International Corp.","slug":"tcm-biotech-international-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"U101","genericName":"U101","slug":"u101","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"U101","genericName":"U101","slug":"u101","phase":"phase_3","mechanism":"U101 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5HalVCOGlCMC1DRVZRU2ZNVTJGVTFwdVZmVXkxN3Z5U3V5VHJtOTNOTHBzQXM3aDcxcmc3OWlPaWVadWZIS21VX3ZnRmE0M3IzMHNmZzNJemdyblJyaFJxRGdR?oc=5","date":"2026-03-30","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE5XQjltQ2piWk44MXl3Z2VhVTI0eDJsQ1RHMU1ib1FZc1F2N3kxT3ZyMG1iSkxLVDk0Ym9SV0gxOVN4R3dTdHhlNmV2Y2U4UGxoeFVWbg?oc=5","date":"2026-03-06","type":"pipeline","source":"Taiwan News","summary":"Tcm Biotech eyes Taiwan main board listing in April - Taiwan News","headline":"Tcm Biotech eyes Taiwan main board listing in April","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-03","type":"pipeline","source":"The Manila Times","summary":"The largest pharma show in Asia makes its return to Shanghai this June 2026 - The Manila Times","headline":"The largest pharma show in Asia makes its return to Shanghai this June 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxQZjZsZlpHcnpULUhYSUtRN21ua3pSSGN4eEJycjQtMF81SWRDbnotaEVNdWxPUHVoSHFYTjhrM0dWTGxDSDdZTngwcTZLNmFZbmx3ZWwtSzRtTEJsUGVZSlZOOFVRZFpsNFhPa2E3ejkyWGFIN3E3cFFNbVVlQ1NJUmt3VFNRNkY1Z1BiUERTc2dmemNYM0picVh2aXd3cElyNmhaakdDSFZjam5LeVE0bEppSm9GZXIwYU9zdDlFYmxBeEVXMTF3eEl6WGg4ekQ3aG9YeGRMRmp1Rmt4ejJnUmdjTVBha0wtQlRR?oc=5","date":"2026-03-02","type":"pipeline","source":"EQS News","summary":"CPHI & PMEC China The largest pharma show in Asia makes its return to Shanghai this June 2026 - EQS News","headline":"CPHI & PMEC China The largest pharma show in Asia makes its return to Shanghai this June 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOeG9vOHJjRjdxYkgtdmdIS0lMYW5DQl85ZjdXaEdCdHRleE0zR2VDem1LYlAwcmpmTWJTYjI3QVBneEhfYS04eE0tTHc3ZHJGZExsZURRVzhkanI4bG84SEc4VUZMcGh2Q1NwbEJBTHJ5cWFJdUU3WGJhdnNoRkVLZy1yZFhDRmhQcXR2Um16V0w?oc=5","date":"2025-12-09","type":"pipeline","source":"ThinkChina","summary":"Innovative drugs: The new battleground in US-China rivalry - ThinkChina","headline":"Innovative drugs: The new battleground in US-China rivalry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOZWVJazI1ZlpzOXhfTU5ueWUzYmZrSlFHbFM5Z3RGekRzWDItYnBmOWh4dFBTcVhySnowVjV2RVdOSzBPYXNibFFFT0hDRElZekhPcUhOSkViVHdnNGJiV2JRMTh3alZDRWJJZ2YtTGNLckVCR2F1WXZaLTlkZ3c1djRKTlZ5SUlIMnZvZlE4elE4ZGJmZE1lVEJYa3RwOWpoSXVwTFdXRkplNjZBbWE0ZkVNci1UbTV3ZkJhd2VySVFmalJrUThkYVlRaE5tQmlDdmhmMmJDZHNFRTM0WFlOa05R?oc=5","date":"2025-11-04","type":"deal","source":"PR Newswire UK","summary":"From Pandemic Innovation to Global Collaboration: Taiwan's TCM Shines at CPHI Frankfurt 2025 - PR Newswire UK","headline":"From Pandemic Innovation to Global Collaboration: Taiwan's TCM Shines at CPHI Frankfurt 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1rQnJGN2RFYXZKcGVPeWlMSUtGRVJnRHdxOGlGc1RMOGt3N01Za2N0LUtoLUg2LU9FNng3WFhXdlRPYXFTTkNVMW14QmpPZWcxM0VnZ180QXV2NkplNFFTZ0t3?oc=5","date":"2025-10-24","type":"pipeline","source":"HKTDC Research","summary":"Biomedicine Boost As Zhuhai Links Up With Hong Kong and Macao - HKTDC Research","headline":"Biomedicine Boost As Zhuhai Links Up With Hong Kong and Macao","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNQzNvVGlEUTRheEp4RGFvTUdkYzI0ZmRhUUZJRFV5TFlxV1dFSkt3a2d0NWZwRTRCd0ZTcjZTVG1CNUE1NHZCSkJtSFVVUmcwY2QwaTNOcVZPRExBeW9sanhrT2RHZ0hUcldhU1pYRlNXRGplWjlZSGVzN2RvR0dZU0hkLW14Z1VRcVFCLURqUE11LXlvOWZTTXBld29XUnZubDdkLW5BYzVBVWxEejJFYVR0U1BzWmJ3VXVGa1FTMDNTZ0JrQzlmX2NXbGlGYURWZDJWaWFn?oc=5","date":"2025-01-22","type":"pipeline","source":"Reuters","summary":"Henlius Biotech shareholders reject take-private offer from China's Fosun - Reuters","headline":"Henlius Biotech shareholders reject take-private offer from China's Fosun","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQZGpUbXVJS0lFdGVUQXZkemNmaV9WQ1pXVVczby1zU3dJV1FJc3ZzNUlBNjZMamE1czVxakZhbGt1VV9NWDY2OUFYc1FuTmhRMFg0NkwxQzlpQ21ldFJNVGEtU1VCeFMtV01QMXNQYW9TNmVhb3laZGlJb0NSdzBvLTdBT0QySU5kU0RuUmZCRXBDQThValFIUFU3VkpQeVdxaU9aNVNTb3IzRjc5YUo5N1ZrUVRwQUN3NHJ2Sk02b0hfdXVUUkYzZkc4bzhjaE1Oc1UycnZzaElGRnJieTdrXw?oc=5","date":"2024-07-30","type":"pipeline","source":"BioSpace","summary":"China Pharmaceutical Market Estimated to Reach a CAGR of 7.50% during 2024-2032, Impelled by the Rising Geriatric Population - BioSpace","headline":"China Pharmaceutical Market Estimated to Reach a CAGR of 7.50% during 2024-2032, Impelled by the Rising Geriatric Popula","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNZXU1Y0phNzg4LXltaTV6QWQ4ZnMtajRBQ0k1SFZRYnJrUWw5LXNNenlUUWRXSVRmelZuNnRqcGtYdjZmU3VieVl0aUtmZVlUSWNSRGEzUXdjUm9IcWNiMkJxTExfZWM2VlhoV3MyMGYxai1KdEg4OUUxX3FqVEl6VF94blU2eF9mZXN0N3NVd3hDcmc?oc=5","date":"2023-01-12","type":"earnings","source":"全球醫療採購網","summary":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","headline":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQ1poWXlTOFoyU2ZkYldjejIyLTRTNUxLeFF0a2Y2VTZzQ01TTVhOTk11LVdxWVZIMWV4ODJQWGk4RmFacUltclRtazB3ejRuRnVpbUY5RWZ6WHlrVUxLOTlVYnZqS1Z5dy1JOTFZZTc4MURqLTI1Q0dvcC1TREprcTF1UUhpX1VMVzJNV1ROLW00a0VEUERSTkZreFFWTGRNblJZXzNiYk5CRWEwLVFvd09yRnZUYmsyZ0NocXdzSmhLY0k?oc=5","date":"2019-09-25","type":"regulatory","source":"European Pharmaceutical Review","summary":"The 10 latest FDA Orphan Drug Designations for cancer treatments - European Pharmaceutical Review","headline":"The 10 latest FDA Orphan Drug Designations for cancer treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE5NWUxzRjBRZ3hqWnJwV1BpT1g4UmtzSTFZZy1CYzFNVVN2STNQeEpzNWtyTXpYUU5ZeG1PSWVmdWtxOFlsQlE4T0dfZkc5bm9pZVdudw?oc=5","date":"2018-01-26","type":"pipeline","source":"nature.com","summary":"Chinese health biotech and the billion-patient market - nature.com","headline":"Chinese health biotech and the billion-patient market","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}